CD79A and bronchopulmonary dysplasia: The intestinal immune network for IgA production pathway highlights the significant lung–gut axis in BPD, suggesting disrupted mucosal immunity and altered microbiome interactions may influence disease development, supporting potential therapeutic approaches targeting both pulmonary and intestinal inflammation.